Likewise, along with previous beneficial effect of BPC 157 in gastrointestinal tract, and inflammatory bowel disease complications that were accordingly solved (10, 11), poor healing of the fistulas (35), unhealed intestinal anastomosis (42, 43), massive intestinal resection leading to short bowel (43)) this study shows BPC 157's high potential to heal colon-colon anastomosis along with cysteamine colitis, thus, potential to counteract the consequences of the anastomosis for cysteamine colitis, and vice versa, convalescing the increased healing failure of anastomosis healing due to concomitant presentation of severe colitis
three vials gives a small margin
J.FangJ
Off-label use must be prescribed and supervised by a licensed provider
Most side effects, such as nausea or mild rash, go away within a few days after starting the medicine
The two peptides have separate FDA concerns: FDA flagged CJC-1295 for limited clinical data and serious adverse events including increased heart rate and systemic vasodilatory reaction
